The results of immunohistochemical analysis of Akt S473 phosphorylation indicate that activated Akt is a potential predictive biomarker of radiotherapy response in patients with HNSCC and cervical cancer [35, 36]. This evidence concerns the gene AKT1 and cervical carcinoma.